Report: Molecular Diagnostics: Revolution or Hype TOC

1. Executive Summary

2. Introduction

3. The current situation - public environment and politics in Europe

3.1. Politics: 3.1.1. Public Awareness; 3.1.2. Patent Situation 3.1.3. Standards & Quality; 3.1.4. Reimbursement

4. The European Market of Molecular Diagnostics

4.1. Overview
4.2. Nucleic Acid Purification: 4.2.1. The Market; 4.2.2. Drivers & Restraints; 4.2.3. Forecasting
4.3. NA amplification: 4.3.1. Market & Methods; 4.3.2. Automation; 4.3.3. Driver & Restraints; 4.3.4. Forecasting

5. NAT Applications

5.1. Blood Testing/Infectious Diseases: 5.1.1. The Market; 5.1.2. Forecasting
5.2. Cancer: 5.2.1. The Market; 5.2.2. Forecasting
5.3. SNPs: 5.3.1. The Market; 5.3.2. Forecasting
5.4. Food Diagnostics: 5.4.1. The Market; 5.4.2. Forecasting

6. Trends in Molecular Diagnostics

6.1. Pharmacogenomics: 6.1.1. The Market; 6.1.2. Drivers, Restraints and Forecasting
6.2. DNA Microarrays: 6.2.1. The Technique; 6.2.2. The Market; 6.2.3. Emerging Markets; 6.2.4. Drivers and Restraints; 6.2.5. Forecast

7. Asia – Market and Chance

7.1. The Market – Overview
7.2. Selected Asian Markets: 7.2.1. The Elite (Japan, Australia, New Zealand); 7.2.2. Developing Markets (India, China)
7.3. Outlook

8. Companies